ISSN (Print) - 0012-9976 | ISSN (Online) - 2349-8846

A+| A| A-

PATENTS-US Rewriting the Rules

sector is an old trick in the MNC book. Curiously at no time did [he government consider reviewing the range of vitamin C formulations being produced. According to the WHO list of essential drugs, vitamin C is necessary in a single- ingredient compound of 50 mg. Any number of experts will today point out the irrelevance of multivitamin products and studies by qualified experts in the field have shown that therapeutic high-dose multivitamin combinations such as Becosules, Surbex-T, Redoxon are not only ineffective but inappropriate. This is because specific vitamin deficiencies are best treated by single ingredient products which deliver the drug in sufficient quantities. Consumption of unnecessary vitamins is not prophylactic because exces vitamins cannot be stored in the body but are simply expelled. In addition deficiencies of vitamins, which are generally available in sufficient quantities in foods, are more likely among those who can hardly afford to buy Becosules Surbex-T or even multivits. The consumption of vitamin C for treatment of colds is again a questionable usage and has not been proven, neither for that matter is the vitamin an essential component of antibiotic or analgesic preparations. A rational study of vitamin C products would probably have shown even the below par production of the bulk drug to be in excess of the real need- PATENTS US Rewriting the Rules Vinod Vyasulu writes:

Dear Reader,

To continue reading, become a subscriber.

Explore our attractive subscription offers.

Click here

Back to Top